{"id":"https://openalex.org/keywords/neratinib","display_name":"neratinib","description":"An oral, irreversible tyrosine kinase inhibitor that targets HER-family receptors and is used to treat HER2-positive cancers.","display_name_alternatives":["HKI-272","HKI272","Nerlynx"],"ids":{"openalex":"https://openalex.org/keywords/neratinib","wikidata":"https://www.wikidata.org/wiki/Q6995920"},"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.5002,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.5002,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"works_count":1675,"cited_by_count":29733,"works_api_url":"https://api.openalex.org/works?filter=keywords.id:keywords/neratinib","updated_date":"2026-10-22T04:07:25","created_date":"2022-04-12T19:38:12"}